Levofloxacin and Atropine sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levofloxacin (levofloxacin; sodium chloride) and Atropine sulfate (atropine sulfate). Common drug interactions include cerebral haemorrhage among females and dehydration among males.

The phase IV clinical study analyzes what interactions people have when they take Levofloxacin and Atropine sulfate. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Levofloxacin?

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is often used in sinusitis. eHealthMe is studying from 16,335 Levofloxacin users. Check the latest studies of Levofloxacin.

What is Atropine sulfate?

Atropine sulfate has active ingredients of atropine sulfate. eHealthMe is studying from 3,485 Atropine sulfate users. Check the latest studies of Atropine sulfate.



On Jul, 12, 2026

28 people who take Levofloxacin and Atropine sulfate together, and have interactions are studied.

Levofloxacin and Atropine sulfate drug interactions.

What are the common drug interactions of Levofloxacin and Atropine Sulfate, by gender? *:

female:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Dehydration (dryness resulting from the removal of water)
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  10. Hyperglycaemia (high blood sugar)

male:

  1. Dehydration (dryness resulting from the removal of water)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  4. Cardiac failure acute
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Pyrexia (fever)
  7. Upper respiratory tract infection
  8. Abdominal hernia
  9. Alveolar proteinosis (alveolar proteinosis (pap) is a rare disease of the lungs in which abnormal accumulation of surfactant occurs within the alveoli)
  10. Anxiety

What are the common drug interactions of Levofloxacin and Atropine Sulfate, by age (0-1 to 60+)? *:

0-1:

  1. Apnoeic attack
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Dehydration (dryness resulting from the removal of water)
  5. Gastroenteritis (inflammation of stomach and intestine)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  9. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

2-9:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
  3. Infection
  4. Enterococcal infection
  5. Enterococcal sepsis
  6. Neuroblastoma (a cancer that forms in your nerve tissue)

10-19:

n/a

20-29:

  1. Pulmonary tuberculosis (lungs tuberculosis)
  2. Upper respiratory tract infection
  3. Corneal epithelium disorder (outer layer diseases of cornea)
  4. Dysuria (painful or difficult urination)
  5. Eye irritation
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Micturition urgency (urgency to pass the urine)
  8. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  9. Urine abnormality

30-39:

n/a

40-49:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Stent placement
  3. Ventricular extrasystoles (premature cardiac contraction)
  4. Pyrexia (fever)
  5. Anaemia (lack of blood)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Cellulitis (infection under the skin)
  9. Drug eruption (adverse drug reaction of the skin)
  10. Hepatitis c

50-59:

  1. Anxiety
  2. Dehydration (dryness resulting from the removal of water)
  3. Vomiting
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  6. Dyspnoea (difficult or laboured respiration)
  7. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  8. Hyperglycaemia (high blood sugar)
  9. Inflammation
  10. Renal failure acute (rapid kidney dysfunction)

60+:

  1. Corneal deposits
  2. Endophthalmitis (inflammation of the internal coats of the eye)
  3. Haemoglobin decreased
  4. Haemorrhage (bleeding)
  5. Platelet count decreased
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Reaction to drug preservatives
  8. Red blood cell count decreased
  9. Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
  10. White blood cell count increased

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 4 people, 14.29%
  2. Stable Angina (a constant chest pain): 3 people, 10.71%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 10.71%
  4. Inflammation: 3 people, 10.71%
  5. High Blood Pressure: 3 people, 10.71%
  6. Hepatitis C: 3 people, 10.71%
  7. Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 3 people, 10.71%
  8. Infection: 2 people, 7.14%
  9. Hypotension (abnormally low blood pressure): 2 people, 7.14%
  10. Hypokalemia (low potassium): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Levofloxacin and Atropine sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levofloxacin and Atropine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atropine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atropine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levofloxacin; sodium chloride and atropine sulfate (the active ingredients of Levofloxacin and Atropine sulfate, respectively), and Levofloxacin and Atropine sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: